John J Treanor

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi request reprint Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults
    John Treanor
    Infectious Diseases Unit, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Vaccine 20:1099-105. 2002
  2. ncbi request reprint Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant
    John J Treanor
    University of Rochester School of Medicine, Rochester, NY, United States Electronic address
    Vaccine 31:5760-5. 2013
  3. pmc Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains
    John J Treanor
    Department of Medicine, University of Rochester Medical Center, NY, USA
    Clin Infect Dis 55:951-9. 2012
  4. pmc Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
    Lisa A Jackson
    Group Health Research Institute, Seattle, Washington, USA
    BMC Infect Dis 10:71. 2010
  5. ncbi request reprint Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses
    J J Treanor
    Infectious Diseases Unit, Department of Medicine, University of Rochester School of Medicine, Box 689, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Vaccine 18:899-906. 1999
  6. ncbi request reprint Rapid licensure of a new, inactivated influenza vaccine in the United States
    John J Treanor
    University of Rochester, Rochester, New York 14642, USA
    Hum Vaccin 1:239-44. 2005
  7. ncbi request reprint Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults
    John J Treanor
    Infectious Disease Division, University of Rochester, Rochester, New York 14642, USA
    J Infect Dis 193:1223-8. 2006
  8. ncbi request reprint Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
    John J Treanor
    Department of Medicine, University of Rochester, Rochester, NY, USA
    N Engl J Med 354:1343-51. 2006
  9. doi request reprint Recombinant proteins produced in insect cells
    John Treanor
    Infectious Diseases Division, Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Curr Top Microbiol Immunol 333:211-25. 2009
  10. ncbi request reprint Immune correlates of protection against influenza in the human challenge model
    J Treanor
    Infectious Diseases Unit, University of Rochester Medical Center, Rochester, NY 14642, USA
    Dev Biol (Basel) 115:97-104. 2003

Detail Information

Publications56

  1. ncbi request reprint Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults
    John Treanor
    Infectious Diseases Unit, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Vaccine 20:1099-105. 2002
    ..These results suggest that when vaccine is in short supply, a strategy using a half dose in healthy adults could increase the number of people vaccinated with relatively little adverse impact on vaccine immunogenicity...
  2. ncbi request reprint Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant
    John J Treanor
    University of Rochester School of Medicine, Rochester, NY, United States Electronic address
    Vaccine 31:5760-5. 2013
    ..The rHA vaccine was tested with and without the adjuvant glucopyranosyl lipid A/stable emulsion (GLA/SE)...
  3. pmc Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains
    John J Treanor
    Department of Medicine, University of Rochester Medical Center, NY, USA
    Clin Infect Dis 55:951-9. 2012
    ..We conducted an assessment of the effectiveness of US influenza vaccines during the 2010-2011 season...
  4. pmc Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
    Lisa A Jackson
    Group Health Research Institute, Seattle, Washington, USA
    BMC Infect Dis 10:71. 2010
    ..The aim of this study was to assess the efficacy, safety, reactogenicity, and immunogenicity of a trivalent inactivated split virion influenza vaccine (TIV) in healthy adults over two influenza seasons in the US...
  5. ncbi request reprint Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses
    J J Treanor
    Infectious Diseases Unit, Department of Medicine, University of Rochester School of Medicine, Box 689, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Vaccine 18:899-906. 1999
    ..These results are consistent with those of previous studies using monovalent preparations of cold-adapted influenza vaccine in this model, and indicate that CAIV-T will be an effective means to prevent influenza illness in adults...
  6. ncbi request reprint Rapid licensure of a new, inactivated influenza vaccine in the United States
    John J Treanor
    University of Rochester, Rochester, New York 14642, USA
    Hum Vaccin 1:239-44. 2005
    ..We evaluated a split virus TIV (Fluarix, GSK), to generate data supportive of a license application in the US...
  7. ncbi request reprint Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults
    John J Treanor
    Infectious Disease Division, University of Rochester, Rochester, New York 14642, USA
    J Infect Dis 193:1223-8. 2006
    ..Influenza-virus hemagglutinin (HA) protein expressed in insect cells by recombinant baculovirus is a candidate influenza vaccine...
  8. ncbi request reprint Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
    John J Treanor
    Department of Medicine, University of Rochester, Rochester, NY, USA
    N Engl J Med 354:1343-51. 2006
    ..Influenza A (H5N1) viruses could cause a severe worldwide epidemic, with high attack rates, large numbers of deaths and hospitalizations, and wide disruption. Effective vaccines against these viruses in humans are urgently needed...
  9. doi request reprint Recombinant proteins produced in insect cells
    John Treanor
    Infectious Diseases Division, Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Curr Top Microbiol Immunol 333:211-25. 2009
    ..Recombinant approaches may be extremely valuable in combating future pandemics and further studies of recombinant pandemic vaccines in humans are needed...
  10. ncbi request reprint Immune correlates of protection against influenza in the human challenge model
    J Treanor
    Infectious Diseases Unit, University of Rochester Medical Center, Rochester, NY 14642, USA
    Dev Biol (Basel) 115:97-104. 2003
    ..Use of a consistent method for assessing mucosal IgA between studies may help to derive a target level for vaccination...
  11. ncbi request reprint Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial
    John J Treanor
    University of Rochester, Rochester, NY, USA
    JAMA 297:1577-82. 2007
    ..A high priority in vaccine research is the development of influenza vaccines that do not use embryonated eggs as the substrate for vaccine production...
  12. ncbi request reprint Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group
    J J Treanor
    Infectious Diseases Unit, University of Rochester, NY 14642, USA
    JAMA 283:1016-24. 2000
    ..Previous studies have shown oseltamivir, a neuraminidase inhibitor, to be effective in preventing influenza and treating experimental influenza...
  13. ncbi request reprint Respiratory viral infections in the elderly
    J Treanor
    Infectious Disease Unit, University of Rochester School of Medicine, NY 14642, USA
    Antiviral Res 44:79-102. 1999
    ..Understanding of the immunology and pathogenesis of these infections in elderly adults is in its infancy, and considerable additional work will need to be performed towards development of effective control measures...
  14. ncbi request reprint Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
    J J Treanor
    Infectious Diseases Unit, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Vaccine 19:1732-7. 2001
    ..These results suggest that baculovirus-expressed H5 HA can induce functional antibody in individuals who have not had prior exposure to H5 viruses, but that further studies to improve the immunogenicity of the vaccine are needed...
  15. doi request reprint Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial
    John J Treanor
    University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA john
    Vaccine 29:7733-9. 2011
    ..We conducted this study to determine the protective efficacy a recombinant, baculovirus-expressed seasonal trivalent influenza virus hemagglutinin (rHA0) vaccine (FluBlok(®))...
  16. pmc B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination
    Mark Y Sangster
    David H Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY, USA
    Clin Vaccine Immunol 20:867-76. 2013
    ..They also emphasize the need to clarify how the level of circulating stalk-reactive Abs relates to resistance to influenza...
  17. pmc Antigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systems
    Felix W Santiago
    New York Influenza Center of Excellence, David H Smith Center for Vaccine Biology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 609, Rochester, NY 14642, USA felix
    Vaccine 30:4606-16. 2012
    ..Marked differences in the behavior of the individual proteins was evident suggesting that they are not equal when being used to detect an immune response. They were, nevertheless, similar at eliciting neutralizing antibody responses...
  18. ncbi request reprint Experimental infection of humans with A2 respiratory syncytial virus
    F Eun Hyung Lee
    Department of Medicine, University of Rochester School of Medicine and Dentistry, Box 689, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Antiviral Res 63:191-6. 2004
    ..This model provides a safe and efficient mechanism for proof-of-concept studies of anti-viral agents and RSV vaccines, as well as for investigation of immune responses to infection...
  19. ncbi request reprint Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant
    Nega Ali Goji
    University of Rochester Medical Center, Rochester, New York 14642, USA
    J Infect Dis 198:635-41. 2008
    ..We administered a single dose of influenza A/Vietnam/1203/2004 (H5N1, clade 1) vaccine to subjects who had received 2 doses of influenza A/Hong Kong/156/1997 (H5N1, clade 0) vaccine in 1998...
  20. doi request reprint Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults
    John J Treanor
    University of Rochester, School of Medicine and Dentistry, 601 Elmwood Ave, Box 689, Rochester, NY 14642, USA
    Vaccine 28:8268-74. 2010
    ..We evaluated a novel influenza vaccine consisting of the globular head of the HA1 domain of the A/Solomon Islands/3/2006 (H1N1) influenza virus (VAX125) genetically fused to the TLR5 ligand, flagellin, and produced in E. coli...
  21. pmc Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus
    Felix W Santiago
    New York Influenza Center of Excellence, University of Rochester Medical Center, Rochester, NY, USA
    Vaccine 29:8888-97. 2011
    ..These findings suggest that pre-vaccination against H5 influenza has the potential to prime immunity against emerging drifted H5 strains, and could also lower the dose requirements of vaccination in the event of a pandemic...
  22. doi request reprint Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older
    Ann R Falsey
    Department of Medicine, Rochester General Hospital, Rochester, NY, USA
    J Infect Dis 200:172-80. 2009
    ..To improve the immunogenicity of influenza vaccine, a high-dose (HD) trivalent, inactivated influenza vaccine was developed...
  23. pmc Mercury levels in premature and low birth weight newborn infants after receipt of thimerosal-containing vaccines
    Michael E Pichichero
    University of Rochester, Rochester, NY, USA
    J Pediatr 155:495-9. 2009
    ....
  24. pmc Increase in IFNγ(-)IL-2(+) cells in recent human CD4 T cell responses to 2009 pandemic H1N1 influenza
    Jason M Weaver
    David H Smith Center for Vaccine Biology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America
    PLoS ONE 8:e57275. 2013
    ....
  25. pmc Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine
    Xiao Song He
    Department of Medicine, Stanford University School of Medicine, Stanford, USA
    J Infect Dis 207:288-96. 2013
    ....
  26. ncbi request reprint Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects
    John Treanor
    Infectious Diseases Unit, University of Rochester School of Medicine, 601 Elmwood Avenue, Room 3 6308, Rochester, NY 14642 0001, USA
    Vaccine 24:254-62. 2006
    ..Further evaluation of mucosal influenza immunization using the proteosome adjuvant/delivery system is clearly warranted...
  27. doi request reprint Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines
    Michael E Pichichero
    Department of Microbiology Immunology, Pediatrics, and Medicine, University of Rochester, Rochester, New York 14642, USA
    Pediatrics 121:e208-14. 2008
    ..We conducted a pharmacokinetic study to assess blood levels and elimination of ethyl mercury after vaccination of infants with thimerosal-containing vaccines...
  28. ncbi request reprint Pandemic (avian) influenza
    Sumanth Rajagopal
    Department of Medicine, Infectious Diseases Division, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Semin Respir Crit Care Med 28:159-70. 2007
    ..g., adamantanes and neuraminidase inhibitors)...
  29. ncbi request reprint Psychosocial factors and the response to influenza vaccination in older adults
    Jan A Moynihan
    Department of Psychiatry, University of Rochester Medical Center, Box PSYCH, 300 Crittenden Blvd, Rochester, NY 14642, USA
    Psychosom Med 66:950-3. 2004
    ..We examined the influence of psychological state (depression, negative affect, perceived stress) and social support on pre- and post-vaccination response to influenza vaccine...
  30. ncbi request reprint Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study
    Michael E Pichichero
    Department of Microbiology Immunology, University of Rochester, Rochester, New York, NY, USA
    Lancet 360:1737-41. 2002
    ..We aimed to measure concentrations of mercury in blood, urine, and stools of infants who received such vaccines...
  31. doi request reprint New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain
    Gregory A Poland
    Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN 55905, USA
    Vaccine 31:A1-20. 2013
    ....
  32. pmc CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses
    Kristin Scheible
    New York Influenza Center of Excellence, David H Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA
    Vaccine 29:2159-68. 2011
    ....
  33. pmc Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization
    Jessica L Halliley
    Division of Pulmonary and Critical Care Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Vaccine 28:3582-7. 2010
    ..The kinetics of this response and the relationship of circulating ASCs to protective antibody titers have not been completely explored...
  34. ncbi request reprint Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody
    James J Kobie
    Infectious Diseases Division, University of Rochester Medical Center, Rochester NY 14642, USA and
    Immunol Invest 43:606-15. 2014
    ..These results demonstrate a mobilization of peripheral blood myeloid DC following vaccination and indicate these cells are potential biomarkers of immune response. ..
  35. ncbi request reprint Fever and progressive respiratory failure in three elderly family members
    F Eun Hyung Lee
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Rochester Medical Center, 601 Elmwood Ave, Box 692, Rochester, NY 14642, USA
    Chest 128:1863-4, 1865-7. 2005
  36. pmc Label-free, arrayed sensing of immune response to influenza antigens
    Charles R Mace
    Department of Biochemistry and Biophysics, University of Rochester, Rochester, NY 14642, USA
    Talanta 83:1000-5. 2011
    ....
  37. ncbi request reprint Influenza vaccine--outmaneuvering antigenic shift and drift
    John Treanor
    Infectious Diseases Unit, University of Rochester Medical Center, Rochester, NY, USA
    N Engl J Med 350:218-20. 2004
  38. pmc B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant
    Jane Baer
    David H Smith Center for Vaccine Biology and Immunology, Aab Institute for Biomedical Sciences, Department of Microbiology and Immunology, Rochester, NY, USA
    Vaccine 28:907-15. 2010
    ..These observations suggest prior vaccination against H5 influenza HA induces cellular immune responses that cross-react among drifted variants, without precluding a response to new, or existing HA strains...
  39. ncbi request reprint Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults
    John Treanor
    Department of Medicine, Division of Infectious Diseases, University of Rochester Medical Center, Rochester, NY 14642, USA
    Vaccine 24:6913-23. 2006
    ..This suggests that local immune events in the tissue are distinct from the parameters measured in the peripheral blood...
  40. pmc CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine
    Jennifer L Nayak
    Department of Pediatrics, Department of Pediatrics, Division of Infectious Diseases, University of Rochester Medical Center, Rochester, NY 14642, USA
    J Infect Dis 207:297-305. 2013
    ....
  41. pmc Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor
    James J Kobie
    Division of Allergy, Immunology and Rheumatology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 695, Rochester, NY 14642, USA
    Arthritis Res Ther 13:R209. 2011
    ..Therefore, we asked if short-term effector (d5-d10) and memory (1 month or later) B cell responses to antigen were compromised in RA patients treated with anti-TNF therapy...
  42. ncbi request reprint Clinical responses to undiluted and diluted smallpox vaccine
    Sharon E Frey
    Department of Medicine, National Institute of Allergy and Infectious Diseases Vaccine and Treatment Evaluation Unit, Saint Louis University School of Medicine, St Louis, USA
    N Engl J Med 346:1265-74. 2002
    ..To evaluate the potential to increase the supply of smallpox vaccine (vaccinia virus), we compared the response to vaccination with 10(8.1), 10(7.2), and 10(7.0) plaque-forming units (pfu) of vaccinia virus per milliliter...
  43. pmc Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding
    Ann R Falsey
    Department of Medicine Infectious Disease Unit, Rochester General Hospital, University of Rochester School of Medicine and Dentistry, Rochester, New York 14621, USA
    J Clin Microbiol 41:4160-5. 2003
    ..Quantitative RT-PCR has an excellent correlation with viral titers, as measured by culture, and should be a useful tool for future studies addressing viral load and disease pathogenesis...
  44. pmc Chronic inhibition of cyclooxygenase-2 attenuates antibody responses against vaccinia infection
    Matthew P Bernard
    Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Vaccine 28:1363-72. 2010
    ..These new findings support an essential role for Cox-2 in regulating humoral immunity...
  45. ncbi request reprint Weathering the influenza vaccine crisis
    John Treanor
    Infectious Diseases Unit, University of Rochester Medical Center, Rochester, NY, USA
    N Engl J Med 351:2037-40. 2004
  46. pmc Simulation and prediction of the adaptive immune response to influenza A virus infection
    Ha Youn Lee
    Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York 14642, USA
    J Virol 83:7151-65. 2009
    ..We further compared alternative model structures, for example, B-cell activation directly by the virus versus that through professional antigen-presenting cells or dendritic cell licensing of CD8 T cells...
  47. ncbi request reprint Recovery of drug-resistant influenza virus from immunocompromised patients: a case series
    Michael G Ison
    Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, 22908, USA
    J Infect Dis 193:760-4. 2006
    ..We describe a novel Asp198Asn NA mutation in an influenza B virus and its decreased susceptibility to both oseltamivir and zanamivir...
  48. ncbi request reprint Dose-dependent neutralizing-antibody responses to vaccinia
    Robert B Belshe
    Center for Vaccine Development, Saint Louis University School of Medicine, St Louis, Missouri 63110, USA
    J Infect Dis 189:493-7. 2004
    ..Larger lesion size and fever after vaccination were associated with significantly higher neutralizing-antibody titers after vaccination...
  49. pmc Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans
    Matthew R Sandbulte
    Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, Tennessee, United States of America
    PLoS Med 4:e59. 2007
    ..We hypothesized that an immune response to huN1 could mediate cross-protection against H5N1 influenza virus infection...
  50. ncbi request reprint Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans
    Kenneth M Zangwill
    University of California, Los Angeles, CA, USA
    J Infect Dis 197:580-3. 2008
    ..5-mug-dose groups had a MN GMT > or =1:40, respectively. Five months later, MN GMTs were significantly greater than those after the second dose. (..
  51. ncbi request reprint Positive emotional style predicts resistance to illness after experimental exposure to rhinovirus or influenza a virus
    Sheldon Cohen
    Department of Psychology, Carnegie Mellon University, 5000 Forbes Avenue, Pittsburgh, PA 15213 3890
    Psychosom Med 68:809-15. 2006
    ..This work did not control for social and cognitive factors closely associated with PES. We replicate the original study using a different virus and controls for these alternative explanations...
  52. ncbi request reprint Vaccines for seasonal and pandemic influenza
    Kristin L Nichol
    University of Minnesota and Minneapolis VA Medical Center, Minneapolis, MN, USA
    J Infect Dis 194:S111-8. 2006
    ..Additional experimental approaches are required to achieve the ultimate goal for seasonal and pandemic influenza prevention--namely, the ability to generate broadly cross-reactive and durable protection in humans...
  53. doi request reprint Objective and subjective socioeconomic status and susceptibility to the common cold
    Sheldon Cohen
    Department of Psychology, Carnegie Mellon University, Department of Otolaryngology, Pittsburgh s Children s Hospital, Pittsburgh, PA 15213, USA
    Health Psychol 27:268-74. 2008
    ..We ask whether subjective socioeconomic status (SES) predicts who develops a common cold when exposed to a cold virus...
  54. ncbi request reprint Loneliness, social network size, and immune response to influenza vaccination in college freshmen
    Sarah D Pressman
    Department of Psychology, Carnegie Mellon University, Pittsburgh, PA 15213, USA
    Health Psychol 24:297-306. 2005
    ..None of these variables were associated with social network size, and hence none were potential mediators of the relation between network size and immunization response...
  55. ncbi request reprint Psychological stress and antibody response to influenza vaccination: when is the critical period for stress, and how does it get inside the body?
    Gregory E Miller
    Department of Psychology, University of British Columbia, Vancouver, Canada
    Psychosom Med 66:215-23. 2004
    ....
  56. pmc Infection-induced proinflammatory cytokines are associated with decreases in positive affect, but not increases in negative affect
    Denise Janicki-Deverts
    Department of Psychology, Carnegie Mellon University, Pittsburgh, PA, USA
    Brain Behav Immun 21:301-7. 2007
    ..There were no associations between cytokines and negative affect. Findings support a causal association between pathogen-induced local cytokine production and changes in positive affect over a 24-h timeline...